Fuchs SY - Search Results

1

SCF(HOS) ubiquitin ligase mediates the ligand-induced down-regulation of the interferon-alpha receptor.

Kumar KG, Tang W, Ravindranath AK, Clark WA, Croze E, Fuchs SY. Kumar KG, et al. Among authors: fuchs sy. EMBO J. 2003 Oct 15;22(20):5480-90. doi: 10.1093/emboj/cdg524. EMBO J. 2003. PMID: 14532120 Free PMC article.

2

Inhibition of HOS expression and activities by Wnt pathway.

Spiegelman VS, Tang W, Katoh M, Slaga TJ, Fuchs SY. Spiegelman VS, et al. Among authors: fuchs sy. Oncogene. 2002 Jan 24;21(5):856-60. doi: 10.1038/sj.onc.1205132. Oncogene. 2002. PMID: 11850814

3

Induction of homologue of Slimb ubiquitin ligase receptor by mitogen signaling.

Spiegelman VS, Tang W, Chan AM, Igarashi M, Aaronson SA, Sassoon DA, Katoh M, Slaga TJ, Fuchs SY. Spiegelman VS, et al. Among authors: fuchs sy. J Biol Chem. 2002 Sep 27;277(39):36624-30. doi: 10.1074/jbc.M204524200. Epub 2002 Jul 31. J Biol Chem. 2002. PMID: 12151397 Free article.

4

Recognition of substrate and Skp1 by the Homologue of Slimb (HOS) ubiquitin ligase receptor D role of the F-box.

Herter JR, Fuchs SY. Herter JR, et al. Among authors: fuchs sy. Med Sci Monit. 2002 Aug;8(8):BR283-8. Med Sci Monit. 2002. PMID: 12165731

5

Interaction of Epstein-Barr virus latent membrane protein 1 with SCFHOS/beta-TrCP E3 ubiquitin ligase regulates extent of NF-kappaB activation.

Tang W, Pavlish OA, Spiegelman VS, Parkhitko AA, Fuchs SY. Tang W, et al. Among authors: fuchs sy. J Biol Chem. 2003 Dec 5;278(49):48942-9. doi: 10.1074/jbc.M307962200. Epub 2003 Sep 30. J Biol Chem. 2003. PMID: 14523018 Free article.

6

The many faces of beta-TrCP E3 ubiquitin ligases: reflections in the magic mirror of cancer.

Fuchs SY, Spiegelman VS, Kumar KG. Fuchs SY, et al. Oncogene. 2004 Mar 15;23(11):2028-36. doi: 10.1038/sj.onc.1207389. Oncogene. 2004. PMID: 15021890 Review.

7

Negative regulation of prolactin receptor stability and signaling mediated by SCF(beta-TrCP) E3 ubiquitin ligase.

Li Y, Kumar KG, Tang W, Spiegelman VS, Fuchs SY. Li Y, et al. Among authors: fuchs sy. Mol Cell Biol. 2004 May;24(9):4038-48. doi: 10.1128/MCB.24.9.4038-4048.2004. Mol Cell Biol. 2004. PMID: 15082796 Free PMC article.

8

Phosphorylation and specific ubiquitin acceptor sites are required for ubiquitination and degradation of the IFNAR1 subunit of type I interferon receptor.

Kumar KG, Krolewski JJ, Fuchs SY. Kumar KG, et al. Among authors: fuchs sy. J Biol Chem. 2004 Nov 5;279(45):46614-20. doi: 10.1074/jbc.M407082200. Epub 2004 Aug 26. J Biol Chem. 2004. PMID: 15337770 Free article.

9

Targeting beta-transducin repeat-containing protein E3 ubiquitin ligase augments the effects of antitumor drugs on breast cancer cells.

Tang W, Li Y, Yu D, Thomas-Tikhonenko A, Spiegelman VS, Fuchs SY. Tang W, et al. Among authors: fuchs sy. Cancer Res. 2005 Mar 1;65(5):1904-8. doi: 10.1158/0008-5472.CAN-04-2597. Cancer Res. 2005. PMID: 15753389

10

Tumor suppressor activities of the Fbw7 E3 ubiquitin ligase receptor.

Fuchs SY. Fuchs SY. Cancer Biol Ther. 2005 May;4(5):506-8. doi: 10.4161/cbt.4.5.1703. Epub 2005 May 5. Cancer Biol Ther. 2005. PMID: 15908780 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

162 results

Search Page

Filters